Lion Point Capital

Latest statistics and disclosures from Lion Point Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are SMTC, IWM, MRNS, ARDX, MIST, and represent 88.79% of Lion Point Capital's stock portfolio.
  • Added to shares of these 6 stocks: SMTC, MIST, HARP, NFYS, AMLX, REPL.
  • Started 2 new stock positions in NFYS, AMLX.
  • Reduced shares in these 8 stocks: , BATL, DRRX, MCRB, MIRM, ARDX, MRNS, CVX.
  • Sold out of its positions in CVX, DRRX, SPY.
  • Lion Point Capital was a net seller of stock by $-18M.
  • Lion Point Capital has $200M in assets under management (AUM), dropping by -10.94%.
  • Central Index Key (CIK): 0001643354

Tip: Access up to 7 years of quarterly data

Positions held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Lion Point Capital

Lion Point Capital holds 29 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Semtech Corporation (SMTC) 55.7 $111M +2% 5.1M 21.91
 View chart
Ishares Tr Russell 2000 Etf Put Option (IWM) 16.6 $33M 165k 200.71
 View chart
Marinus Pharmaceuticals Com New (MRNS) 11.6 $23M 2.1M 10.87
 View chart
Ardelyx (ARDX) 3.6 $7.1M -2% 1.2M 6.20
 View chart
Milestone Pharmaceuticals (MIST) 1.4 $2.8M +266% 1.7M 1.67
 View chart
Harpoon Therapeutics Com New (HARP) 1.3 $2.6M +177% 229k 11.37
 View chart
Burgerfi International (BFI) 1.2 $2.4M 2.7M 0.86
 View chart
Kiniksa Pharmaceuticals Com Cl A (KNSA) 1.1 $2.3M 131k 17.54
 View chart
Insmed Com Par $.01 (INSM) 1.1 $2.2M 70k 30.99
 View chart
Battalion Oil Corp (BATL) 1.1 $2.1M -41% 222k 9.61
 View chart
Cymabay Therapeutics (CBAY) 1.0 $1.9M 82k 23.62
 View chart
Fennec Pharmaceuticals (FENC) 0.6 $1.2M 110k 11.22
 View chart
Avadel Pharmaceuticals Sponsored Adr (AVDL) 0.6 $1.1M 80k 14.12
 View chart
Enphys Acquisition Corp Cl A Ord Shs (NFYS) 0.4 $834k NEW 78k 10.67
 View chart
Syndax Pharmaceuticals (SNDX) 0.4 $746k 35k 21.61
 View chart
Bluebird Bio (BLUE) 0.4 $733k 531k 1.38
 View chart
Travere Therapeutics (TVTX) 0.4 $701k 78k 8.99
 View chart
Travere Therapeutics Note 2.250% 3/0 (Principal) 0.3 $671k 1.0M 0.67
 View chart
Humacyte (HUMA) 0.3 $667k 235k 2.84
 View chart
Seres Therapeutics (MCRB) 0.2 $477k -50% 341k 1.40
 View chart
Mirum Pharmaceuticals (MIRM) 0.2 $399k -50% 14k 29.52
 View chart
Replimune Group (REPL) 0.2 $358k +21% 43k 8.43
 View chart
Lumos Pharma (LUMO) 0.1 $289k 91k 3.18
 View chart
Amylyx Pharmaceuticals (AMLX) 0.1 $206k NEW 14k 14.72
 View chart
Aadi Bioscience (AADI) 0.1 $167k 82k 2.02
 View chart
Aclaris Therapeutics (ACRS) 0.1 $122k 116k 1.05
 View chart
Burgerfi International *w Exp 12/16/202 (BFIIW) 0.0 $94k 2.1M 0.04
 View chart
Microsoft Corporation (MSFT) 0.0 $38k 100.00 376.04
 View chart
Alphabet Cap Stk Cl C (GOOG) 0.0 $14k 100.00 140.93
 View chart

Past Filings by Lion Point Capital

SEC 13F filings are viewable for Lion Point Capital going back to 2015

View all past filings